Literature DB >> 25059578

The role of advocacy in the national strategy for maternal death review in Nigeria.

Fred F Achem1, Chris O Agboghoroma2, Moses O Adeoye2.   

Abstract

Strategic advocacy has played a substantial role in the development and implementation of maternal death review (MDR) in Nigeria. Stakeholders that include the Society of Gynaecology and Obstetrics of Nigeria have partnered with the Federal Ministry of Health to ensure a robust arrangement that will guarantee the success of MDR in this country. Consequently, it is envisaged that the program will both contribute to a sustainable reduction in the maternal mortality ratio and promote improvements in maternal health care. The Nigerian experience indicates that the influence of stakeholders, such as professional organizations, is essential to drive the development of MDR programs through provision of advocacy and technical support. The current convergence of factors-including global support, political will, technical innovations, and increased financial resources-provides an ideal opportunity to make MDR a reality for all countries.
Copyright © 2014. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Advocacy; Confidential enquiry into maternal death; FIGO LOGIC initiative; Maternal death review; Maternal mortality; Nigeria

Mesh:

Year:  2014        PMID: 25059578     DOI: 10.1016/j.ijgo.2014.06.004

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

1.  Spousal support during pregnancy in the Nigerian rural context: a mixed methods study.

Authors:  O Arisukwu; C O Igbolekwu; I A Oyekola; E J Oyeyipo; F F Asamu; O N Osueke
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-15       Impact factor: 3.007

2.  Effective strategies for reducing maternal mortality in Isfahan University of Medical Sciences, 2014.

Authors:  Somaye Nosraty; Mojtaba Rahimi; Shahnaz Kohan; Margan Beigei
Journal:  Iran J Nurs Midwifery Res       Date:  2016 May-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.